EmiHCaywoodMDFACP
Pediatric Hematology & Oncology • Wilmington, DENemours-AIDHC Blood and Bone Marrow Transplant, Hematology/Oncology
Dr. Caywood is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 Rockland Road
Wilmington, DE 19803Phone+1 302-651-4200Fax+1 302-651-5510- Is this information wrong?
Summary
- Dr. Emi Caywood is a pediatric hematologist/oncologist in Wilmington, DE and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals, Alfred I. duPont Hospital for Children, and Nemours Children's Hospital. She received her medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 15 years. She is experienced in myeloid leukemia and pediatric bone marrow transplantation.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008
MedStar Health/Georgetown University HospitalResidency, Pediatrics, 2002 - 2005
Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
DE State Medical License Active through 2025
PA State Medical License Active through 2024
MD State Medical License 2005 - 2010
DC State Medical License 2004 - 2005
VA State Medical License 2002 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of PediatricsHematology/Oncology
Clinical Trials
- Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
- Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
- Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Novel Compound Heterozygous ZAP70 R37G A507T Mutations in Infant with Severe Immunodeficiency.Benavides, N., White, J., Sanmillan, M., Thomas, M., Giraudo, C., Le, T., Caywood, E.> ;Journal of Clinical Immunology. 2023 Dec 22
- γδ CD8+ T cells and novel genetic variants in ZAP70 deficiency.Isma Shah, Samuel Chiang, Li Yang, Nagako Akeno, Allison Kelly, Jason White, Emi Caywood, Sharon Hwang, Trong Le> ;Pediatric Allergy and Immunology. 2023 Oct 1
- 7 citationsMeasuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from...Thakar, M., Logan, B., Puck, J., Dunn, E., Buckley, R., Cowan, M., O'Reilly, R., Kapoor, N., Satter, L., Pai, S., Heimall, J., Chandra, S., Ebens, C., Chellapandian, D...> ;Lancet. 2023 Jul 8
- Join now to see all
Hospital Affiliations
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Nemours Children’s Hospital, DelawareWilmington, Delaware
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
